Between March and November 2025, GOSTAR Small Molecules continued steady, high-quality growth across compounds, SAR,…
Vinayak ManeDecember 9, 2025
Between April and July 2025, the GOSTARᵀᴹ TPD database added 20% more content. More than…
Vinayak ManeAugust 11, 2025
In the fast-evolving world of targeted protein degrader discovery and development, meaningful insights often emerge…
Vinayak ManeAugust 11, 2025
Schindellegi, Switzerland, June 2024 – Small molecule toxicity assessment remains a hurdle in drug development,…
Prashant SharmaApril 7, 2025
The GOSTAR™ SAR database has always been the gold standard for medicinal chemists and drug…
Prashant SharmaApril 7, 2025
Protein degradation is an important process in the cell. It helps keep the cell healthy…
Prashant SharmaMarch 19, 2025
Most drug discovery programs prioritize developing orally bioactive small molecules as they are the most…
Prashant SharmaOctober 16, 2024
Precision medicine represents a revolutionary shift towards customized treatments considering essential factors such as genetics,…
Prashant SharmaOctober 3, 2024
The European biotechnology sector is expanding rapidly, contributing to an estimated €106 billion per year…
Prashant SharmaOctober 1, 2024
GOSTAR® is an integrated platform of various standalone databases with cross-indexing of chemical compounds of…
Prashant SharmaSeptember 29, 2023
